This inventor holds 7 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignee: Novartis Ag. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: Heinrich Buettgen: Innovator in Ophthalmic Injection Technology
Introduction
Heinrich Buettgen is a notable inventor based in Rheinfelden, Switzerland. He has made significant contributions to the field of medical technology, particularly in the development of syringes for ophthalmic injections. With a total of seven patents to his name, Buettgen's work has had a meaningful impact on the healthcare industry.
Latest Patents
One of Buettgen's latest inventions is a syringe designed specifically for use in ophthalmic injections. This innovative syringe comprises a body, a stopper, and a plunger. The body features an outlet at one end, while the stopper is positioned within the body to create a variable volume chamber from which fluid can be expelled through the outlet. The plunger includes a contact surface at one end and a rod that extends to a rear portion. This design allows the plunger to force the stopper towards the outlet end, effectively reducing the chamber's volume without moving the stopper away from the outlet.
Career Highlights
Heinrich Buettgen is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions that enhance patient care and treatment options. His dedication to improving medical devices has positioned him as a key figure in the field.
Collaborations
Buettgen has collaborated with several talented individuals in his career, including Marie Picci and Andrew Mark Bryant. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Heinrich Buettgen's contributions to the field of ophthalmic injection technology exemplify his commitment to innovation and patient care. His patents and work at Novartis AG continue to influence the medical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
